Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
India has more women than men for the first time on record, according to government data that also showed a slowing birthrate in the world's second most populous nation. The latest National Family and Health Survey, released by the health ministey on Wednesday
Dr Mansukh Mandaviya
Minister of Health and Family Welfare; Chemicals and Fertilizers,
Government of India
Sponsor
Patient Safety Capsules
Healthcare experts call for providing affordable, simplified digital health solutions to elderly population
Mumbai, November 22, 2021: Hailing the rapid pace of digitization of healthcare sector, experts have called for digital technologies to provide affordable, simple-to-use healthcare solutions to a growing and ageing population, for whom it is usually difficult to accept new technologies.
Ayurvedic community seeks PM’s intervention to include Ayush dept within the framework of NHRP
Chennai, November 23, 2021: Expressing dissent over the way the draft of the ‘National Health Research Policy (NHRP) 2021 was framed by the Department of Health Research (DHR) under the Union health ministry, the ayurvedic community of the traditional knowledge system in the country wanted Prime Minister Narendra Modi to take steps to effect necessary changes for including the Department of Ayush within the framework of the NHRP 2021.
Drug Laws & Policy Injections
DoP calls on industry to make innovation part of business strategy to spur sustainable growthMumbai, November 23, 2021: The Department of Pharmaceuticals (DoP) has called on the pharmaceutical industry to adopt innovation as a driving feature of its business strategy which will help the industry sustain growth and expansion.
DoP endorses KSRPA’s suggestions to amend D&C Act and DPCO Bengaluru, November 22, 2021: The Department of Pharmaceuticals (DoP) has now accepted the Karnataka State Registered Pharmacists Association (KSRPA)’s suggestions related to amendment of the Drugs & Cosmetics Act & Rules and the Drug Price Control Order (DPCO) and would incorporate the same during the revision of the regulations.
NABL releases guidelines for inter-laboratory comparison for calibration laboratoriesMumbai, October 27, 2021: The National Accreditation Board for Testing and Calibration Laboratories (NABL) has released NABL 164: Guide-lines for inter-laboratory comparison for calibration laboratories where formal proficiency testing programmes are not available.
Centre issues fresh advisory to states, UTs over new Covid variantNew Delhi, November 25, 2021: The Centre on Thursday asked all states and union territories to conduct rigorous screening and testing of all international travellers coming from or transiting through South Africa, Hong Kong and Botswana, where a new COVID-19 variant of serious public health implications has been reported.
Kerala DC calls on IPEC to adopt US FDA guidance to ensure quality of excipients used in drug formulationsMumbai, November22, 2021: To ensure the proper performance of an excipient in a drug formulation, Kerala state drugs control department has called on International Pharmaceutical Excipients Council of India (IPEC India) to adopt US FDA’s guidance document for industry which mainly focuses on developing a safety database of pharmaceutical excipients.
SC agrees to hear plea for plan to rehabilitate families affected by COVID-19November 26, 2021: The Supreme Court on Friday sought response from the Centre and all the States on a plea seeking for-mulation and preparation of the national plan for ensuring rehabilitation of families seriously affected by the COVID-19 pandemic.
Pharma Injections
Covaxin is a true example of public private partnership: ICMR DGMumbai, November 25, 2021: The development of Covaxin was made possible with the collaboration between Indian Council of Medical Research (ICMR) and Bharat Biotech and this is a true example of public private partnership, which is marked with trust, transparency and mutual respect, stated Dr Balram Bhargava, director general, ICMR.
Pharmexcil urges govt to lift restriction on export of remdesivir and amphotericin-B injectionsMumbai, November 25, 2021: The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the Union ministry of commerce and industry to lift restriction on export of remdesivir and amphotericin-B injections considering current circumstances of reduction in local caseload of Covid-19 and associated mucormycosis cases.
Serum Institute resumes COVID-19 vaccine exports Mumbai, November 26, 2021: Serum Institute of India, the world’s largest vaccine maker, on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
India, ADB sign $300 bn loan to improve access to healthcare in urban areas of 13 states New Delhi, November24, 2021: Government of India and the Asian Development Bank (ADB) have signed a USD 300 million loan to strengthen and improve access to comprehensive primary healthcare in urban areas of 13 states benefiting over 256 million urban dwellers, including 51 million from slum areas, a statement said on Wednesday.
PCI submits national action plan to Union health ministry to revamp pharmacy education in the country Chennai, November 25, 2021: In line with the Central government’s new education policy, the Pharmacy Council of India (PCI) has prepared a national action plan to revamp pharmacy education in the country and submitted the plan project to the Union health ministry.
Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer November19, 2021: Natco Pharma on Thursday said it has launched a novel fixed-dose combination of Trifluridine and Tipira-cil, used to treat advanced colorectal and gastric cancer, in the country.
Drug Dopes
Retired pharmacists in Kerala form association to motivate serving pharmacists in government sectorChennai, November 27, 2021: To make the pharmaceutical care services more efficient and to motivate hospital pharmacists in government healthcare institutions for providing better pharmacy services to patients, a group of retired pharmacists in Kerala has formed an association with members from all districts in the state. 
Industry seeks single window clearance system at DCGI to facilitate innovationMumbai, November 27, 2021: The pharmaceutical industry has appealed to the government to introduce a single window clearance system at the Drugs Controller General of India (DCGI) office to facilitate innovation of novel drugs, vaccines and biologics.
Pvt Delhi hospital to write ‘pollution-related’ in diagnosis of ICU patients New Delhi, November18, 2021: Amid deteriorating air quality in the national capital, a private city hospital is planning to write “pollution-related” in diagnosis of patients, in what could be a first for a medical facility here. The Holy Family Hospital in Okhla will start this process for their ICU patients, said Dr Sumit Ray, head of the department of critical care at the hospital.
NPPA extends price regulation on oxygen concentrators for six more months New Delhi, November 26, 2021: The National Pharmaceutical Pricing Authority (NPPA) has decided to extend the notification related to price regulation of oxygen concentrators based on the Trade Margin Rationalisation (TMR) approach applicable for six more months, till May 30, 2022.
Health experts express concern over pandemic-led increase to antimicrobial resistance November 17, 2021: Covid-19 has led to a higher antimicrobial resistance with the pandemic impacting antimicrobial stewardship and pushing back years of work to control it, scientists said at a webinar organised by Tata Institute for Genetics and Society.
Pharma entrepreneurs eye novel, lucrative avenues to propel affordability of quality medicinesBengaluru, November 24, 2021: Pharma entrepreneurs are now earnestly looking at novel and lucrative avenues to propel affordability of quality medicines for the masses. For ensuring safe and efficacious medicines are accessible,areas like pharmacovigilance and post-marketing surveillance are also coming to the fore for entrepreneurs to explore as business ventures.
National Injections
Alarming rise in dengue cases jolts Delhi, Centre extends help New Delhi, November22, 2021: The situation in Delhi is getting worse with the city witnessing an alarming spike in dengue cases . Chief Minister of Delhi Arvind Kejriwal has however ensured that the situation will get better within the next 7-10 days with the change in weather. Health experts have also noted that the dengue situation has worsened this year compared to the previous year as people were careful that time due to covid-19 led restrictions. The recent civic report, released on Monday, noted that dengue cases in Delhi mount to over 7,100 this year. Here are the key things to take note of.
Mansukh Mandaviya urges 3 states, 1 UT reporting low vaccination coverage to launch aggressive campaignNovember22, 2021: Union Health Minister Mansukh Mandaviya on Monday urged Manipur, Meghalaya, Nagaland and Pudu-cherry, which have been reporting a low vaccination coverage, to launch aggressive campaign to in-crease the pace and ensure full COVID-19 inoculation of the adult population.
Calcutta HC restrains Shree Baidyanath Ayurved Bhawan from publishing advt in a dispute on Chyawanprash New Delhi, November 27, 2021: The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video advertisements for “Baidyanath Chyawanprash Special” in a suit filed by Dabur India Limited. Dabur has alleged that the advertisements issued by Shree Baidyanath disparage the goodwill and reputation of Dabur Chyawanprash and other Chyawanprash in the market, as well.
Kerala DC calls on IPEC to adopt US FDA guidance to ensure quality of excipients used in drug formulations Mumbai, November 22, 2021: To ensure the proper performance of an excipient in a drug formulation, Kerala state drugs control department has called on International Pharmaceutical Excipients Council of India (IPEC India) to adopt US FDA’s guidance document for industry which mainly focuses on developing a safety database of pharmaceutical excipients.
INSACOG closely tracking new COVID-19 variant, presence not yet detected in India: Officials November 26, 2021: The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely tracking the new variant of COVID-19 called B.1.1.529 and its presence has not been detected in the country yet, officials said on Friday.
Delhi HC seeks Centre’s stand on booster doses: Everything to know November26, 2021: As many countries around the world are introducing booster shots for COVID-19 vaccine, the Union Gov-ernment of India has yet to take a stand on the issue. Now, the Delhi High Court has asked the Centre to apprise it of its stance on the issue, adding that the decision on booster shots cannot be made on the basis of economics.
Global Injections
Javid says UK must act quickly over public health riskLondon, October 19, 2021: The new Covid variant circulating in South Africa that prompted UK travel restrictions is a "huge interna-tional concern", the health secretary says.
US joins EU in restricting flights from southern Africa over new coronavirus variantNovember27, 2021: The US will restrict travel from South Africa and seven other southern African countries to try to contain a new coronavirus variant spreading there.
WHO Warns of 700,000 More COVID-19 Deaths in Europe by March
November24, 2021: Countries across Europe are facing another surge in coronavirus cases, which could lead to another 700,000 deaths by March 1 if current trends continue, the WHO announced on Tuesday.
Year’s Second Case of Monkeypox Discovered in Maryland
Maryland, November 23, 2021: Health authorities have confirmed that a Maryland resident who recently returned from Nigeria has mon-keypox, making it the second case of the rare but potentially fatal viral illness found in the United States this year.
UK raises alarm over new COVID variant which could beat vaccines
November 27, 2021: Britain on Thursday said it was concerned by a newly identified coronavirus variant spreading in South Africa that might make vaccines less effective and imperil progress made across the world in fighting the pandemic.
CVS Health, Walmart and Walgreens Played Role in Opioid Crisis
November24, 2021: CVS Health, Walmart and Walgreens contributed to opioid overdoses and deaths in two Ohio counties, a federal jury in Cleveland found Tuesday.
PSAIIF PILL
DoP clarifies any agency empanelled with GoI can apply for tender to conduct short and long term study
New Delhi, November 24, 2021: The Department of Pharmaceuticals (DoP) has clarified that any agencies whether government or non-government, which are empanelled with the Ministries or Departments of Government of India with experience are eligible to take part in the tender it has invited for selection of agencies for its long term and short term studies on the policies related to pharma and medical devices industry.
How important it is to improve women’s healthcare amid the pandemic
November 25, 2021: Almost two years back the pandemic struck and since then Covid 19 has affected the life of every individual. Interestingly, Covid virus is gender biased. The infection rates as well as the mortality rates are more in men than in women. Nevertheless, women are at greater risk of exposure to virus as globally around 70 percent of health workers are women and are working in the frontline.
Frequently Asked Questions
Do pulse oximeters have racial bias?
November24, 2021: On Sunday, the UK’s Department of Health and Social Care announced an independent review to find any potential bias in medical items such as pulse oximeters and their impact on patients from various ethnic groups. The development comes amid concerns that many medical devices are designed and cali-brated for White patients. Read More>>>
SUBSCRIBER'S SYMPTOM
Cold weather and heart attack: Reasons and prevention
November25, 2021: There are increased cases of a heart attack during winter. It is necessary to take preventive measures in winters, especially for people at high risk of developing a heart attack. Here are the reasons and ways to prevent heart attack during winter.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Mr Loknath Harish, Pharma Professional It is enjoyable to read the newsletter and to know about the developments in the industry. Keep up the good work.
Mr Ram Athawale, MDThe reader is delighted with the articles you publish every fortnight or bi-monthly. Prescription newsletter is very good.
Mr Malik Jethani, MBBS
Good newsletter which brings an in depth understanding of news events in the Pharma world both nationally and globally. Keep up the good work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
